Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Superinvestors holding VRDN, Q2 2026
No superinvestor reported holding VRDN in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of VRDN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2025
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2025
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−2.0%)
Q2 2025
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+9.5%)
Q1 2025
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+0.4%)
Q4 2024
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+2.8%)
Q3 2024
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−39.6%)
Q2 2024
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+22.9%)
Q1 2024
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+15.8%)
Q4 2023
1 superinvestor holding at quarter end